Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd | Sector: Pharmaceuticals | ISIN: INE685A01028

₹ 1,534.05 (1.02%) icon

23 Mar, 2023, 3:29:57 PM
Open
₹ 1,518.60
Prev. Close
₹ 1,518.60
Turnover(lac)
₹ 1,346.50
Day's High
₹ 1,540.00
Day's Low
₹ 1,513.65
52 Wk High
₹ 1,750.00
52 Wk Low
₹ 1,242.08
Book Value
₹ 211.95
Face Value
₹ 5.00
Mkt. Cap (Cr.)
₹ 51,919.22
P/E
49.01
EPS
30.99
Div. Yield
1.58

Stock View

info icon
Edit Image

BUY

Target | 02 Feb, 2023

1,748.43 (14.54%)

Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.... Read More

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 3/23/2023 3:29:57 PM

    ₹ 1534.05 15.45 1.02
  • Open
  • ₹ 1,518.6
  • Prev. Close
  • ₹ 1,518.6
  • Turnover(Lac.)
  • ₹ 1,346
  • Day's High
  • ₹ 1,540
  • Day's Low
  • ₹ 1,513.65
  • 52 Week's High
  • ₹ 1,750
  • 52 Week's Low
  • ₹ 1,242.08
  • Book Value
  • ₹ 211.95
  • Face Value
  • ₹ 5
  • Mkt Cap (₹ Cr.)
  • 51,919.22
  • P/E
  • 49.01
  • EPS
  • 30.99
  • Divi. Yield
  • 1.58

Corporate Actions

25 Jan , 2023

12:00 AM

Dividend

Dividend amount: 14
Announcement date: 25 Jan , 2023

View Details

12 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

12 Jan , 2023

12:00 AM

15 Dec , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Oct , 2022

12:00 AM

04 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 Jul , 2022

12:00 AM

06 Jul , 2022

12:00 AM

AGM

Announcement date: 06 Jul , 2022

View Details

29 Jun , 2022

12:00 AM

25 May , 2022

12:00 AM

Dividend

Dividend amount: 15
Announcement date: 25 May , 2022

View Details

25 May , 2022

12:00 AM

Dividend

Dividend amount: 8
Announcement date: 25 May , 2022

View Details

06 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

SHAREHOLDING SNAPSHOT
23 March , 2023 | 04:20 PM

PROMOTER - TOTAL71.25%

Indian: 71.25%

Foreign: 0%

NON-PROMOTER - TOTAL 28.75%

Institutions: 20.96%

Non-Institutions: 7.80%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Torrent Pharmaceuticals Ltd News and Update

Article Image
  • 3 hours ago |
  • 4:02 PM

Acquisition done for Rs 18.45 crore.

Article Image
  • IIFL News Service |
  • 6 hours ago |
  • 4:02 PM
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Torrent Pharmaceuticals Ltd

  • Sudhir Mehta

  • Chairman Emeritus
  • Samir Mehta

  • Executive Chairman
  • Shailesh Haribhakti

  • Independent Director
  • H Khaitan

  • Independent Director
  • Ameera Shah

  • Independent Director
  • Nayantara Bali

  • Independent Director
  • Jinesh Shah

  • Director (Operation)
  • Maurice Chagnaud

  • Addtnl Independent Director
  • Aman Mehta

  • Whole Time Director
  • Manish Choksi

  • Independent Director
  • Chintan Trivedi

  • Company Sec. & Compli. Officer

Summary

Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is one of the leading pharmaceutical companies having presence in Indian and global markets. The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India. It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 12 countries with major setups in the US, Germany and Brazil. Apart from this, it has a modern and well-equipped state-of-the-art R&D Centre at Bhat near Ahmedabad, built with an investment of US $ 40 million.Torrent Pharmaceuticals Limited was founded in 1959 as Trinity Laboratories by Late Shri U. N. Mehta. Trinity was later renamed as Torrent Pharmaceuticals Limited and taken public in July 15th, 1972. In 1980, Company started their first manufacturing facility at Vatva and received first export order in year 1983. In year 1986, it started second manufacturing plant at Chhatral. In the year 1995, Torrent Gujarat Biotech Ltd plant was commissioned.In the year 1996, the company acquired the Pharma related investments and business of Torrent Exports Ltd and also commissioned the state-of-the-art R&D centre. In the year 1997, India Infusions Ltd was merged with... Read More


Reports by Torrent Pharmaceuticals Ltd


Reports by Torrent Pharmaceuticals Ltd